(Q34155662)

31 July 2017

title

cNEUPRO: Novel Biomarkers for Neurodegenerative Diseases (English)

1 reference

31 July 2017

0 references

1 reference

17

Hilkka Soininen

0 references

Susanna Schraen

Susanna Schraen

18

0 references

Luc Buée

Luc Buée

4

0 references

Jens Wiltfang

Jens Wiltfang

22

0 references

Henrik Zetterberg

21

Henrik Zetterberg

1 reference

31 July 2017

3

Kaj Blennow

1 reference

31 July 2017

19

Charlotte Teunissen

1 reference

31 July 2017

7

Connie Jimenez

1 reference

31 July 2017

16

Lucilla Parnetti

1 reference

31 July 2017

20

Laszlo Vecsei

1 reference

31 July 2017

13

Chris Morris

1 reference

31 July 2017

1

Philipp Spitzer

1 reference

31 July 2017

8

Peter Klivenyi

1 reference

31 July 2017

9

Piotr Lewczuk

1 reference

31 July 2017

10

Juan Manuel Maler

1 reference

31 July 2017

15

Markus Otto

1 reference

31 July 2017

Hans Wolfgang Klafki

2

1 reference

31 July 2017

Hermann Esselmann

5

1 reference

31 July 2017

Sanna-Kaisa Herruka

6

1 reference

31 July 2017

Katrin Markus

11

1 reference

31 July 2017

Helmut E Meyer

12

1 reference

31 July 2017

Thorsten Müller

14

1 reference

31 July 2017

publication date

19 September 2010

1 reference

International journal of Alzheimer's disease

31 July 2017

published in

1 reference

31 July 2017

volume

2010

1 reference

31 July 2017

page(s)

503-506

1 reference

Creative Commons Attribution 3.0 Unported

31 July 2017

copyright license

start time

19 September 2010

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Clinical proteomics of the cerebrospinal fluid: Towards the discovery of new biomarkers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945639

Tau as a biomarker of neurodegenerative diseases.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945639

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945639

Serum levels of S100B and NSE proteins in Alzheimer's disease patients

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945639

Combining MR imaging, positron-emission tomography, and CSF biomarkers in the diagnosis and prognosis of Alzheimer disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945639

Stem cells in human neurodegenerative disorders--time for clinical translation?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945639

An update on clinical proteomics in Alzheimer's research

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945639

A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945639

Biological marker candidates of Alzheimer's disease in blood, plasma, and serum.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945639

Measurement of ERK 1/2 in CSF from patients with neuropsychiatric disorders and evidence for the presence of the activated form

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945639

CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945639

Identification of novel N-terminal fragments of amyloid precursor protein in cerebrospinal fluid

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945639

Safety of lumbar puncture procedures in patients with Alzheimer's disease.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945639

Plasma biomarkers for mild cognitive impairment and Alzheimer's disease.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945639

Cerebrospinal fluid biomarkers in human genetic transmissible spongiform encephalopathies

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945639

Depletion of one, six, twelve or twenty major blood proteins before proteomic analysis: the more the better?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945639

Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945639

Neurochemical approaches in the laboratory diagnosis of Parkinson and Parkinson dementia syndromes: a review

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945639

Identification of novel APP/Abeta isoforms in human cerebrospinal fluid

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945639

TDP-43 in cerebrospinal fluid of patients with frontotemporal lobar degeneration and amyotrophic lateral sclerosis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945639

Cerebrospinal fluid-optimized two-dimensional difference gel electrophoresis (2-D DIGE) facilitates the differential diagnosis of Creutzfeldt-Jakob disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945639

Evaluation of plasma Abeta(40) and Abeta(42) as predictors of conversion to Alzheimer's disease in patients with mild cognitive impairment

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945639

CSF biomarkers in frontotemporal lobar degeneration with known pathology

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945639

Neurochemical approaches of cerebrospinal fluid diagnostics in neurodegenerative diseases.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945639

Clinical proteomics in neurodegenerative disorders

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945639

Neurochemical dementia diagnostics: State of the art and research perspectives

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945639

Cerebrospinal fluid neurochemical phenotypes in vascular dementias: original data and mini-review

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945639

Mild cognitive impairment: an overview.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945639

Gene expression analysis of frontotemporal lobar degeneration of the motor neuron disease type with ubiquitinated inclusions.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945639

Adult neurogenesis and neurodegenerative disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945639

CSF neurofilaments in frontotemporal dementia compared with early onset Alzheimer's disease and controls

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945639

Hallmarks of protein oxidative damage in neurodegenerative diseases: focus on Alzheimer's disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945639

Evidence of increased oxidative damage in subjects with mild cognitive impairment.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945639

Biomarkers of Alzheimer disease in plasma

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945639

Strategies for disease modification in Alzheimer's disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945639

Looking Backward to Move Forward: Early Detection of Neurodegenerative Disorders

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945639

CSF markers for incipient Alzheimer's disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945639

Decreased CSF-beta-amyloid 42 in Alzheimer's disease and amyotrophic lateral sclerosis may reflect mismetabolism of beta-amyloid induced by disparate mechanisms.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945639

Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945639

Mild cognitive impairment: clinical characterization and outcome

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945639

Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945639

Diagnosis of Creutzfeldt-Jakob disease by measurement of S100 protein in serum: prospective case-control study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945639

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945639

The Clinical Dementia Rating (CDR): current version and scoring rules

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945639

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945639

A4 amyloid protein deposition and the diagnosis of Alzheimer's disease: prevalence in aged brains determined by immunocytochemistry compared with conventional neuropathologic techniques.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945639

Decreased levels of soluble amyloid beta-protein precursor in cerebrospinal fluid of live Alzheimer disease patients

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945639

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945639

Usability of cerebrospinal fluid biomarkers in a tertiary memory clinic.

5 July 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F548145

Safety and acceptability of the research lumbar puncture.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F548145

A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F548145

International quality control survey of neurochemical dementia diagnostics.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F548145

An unbiased, staged, multicentre, validation strategy for Alzheimer's disease CSF tau levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F548145

Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F548145

Combined CSF tau, p-tau181 and amyloid-beta 38/40/42 for diagnosing Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F548145

Measurement of alpha- and beta-secretase cleaved amyloid precursor protein in cerebrospinal fluid from Alzheimer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F548145

Toward a reliable distinction between patients with mild cognitive impairment and Alzheimer-type dementia versus major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F548145

Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer's disease: a multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F548145

The cerebrospinal fluid level of glial fibrillary acidic protein is increased in cerebrospinal fluid from Alzheimer's disease patients and correlates with severity of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F548145

Glial fibrillary acidic protein and protein S-100B: different concentration pattern of glial proteins in cerebrospinal fluid of patients with Alzheimer's disease and Creutzfeldt-Jakob disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F548145

Cerebrospinal fluid, serum and plasma protein oxidation in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F548145

Protein glycation, oxidation and nitration adduct residues and free adducts of cerebrospinal fluid in Alzheimer's disease and link to cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F548145

Multiplexed proteomic analysis of oxidation and concentrations of cerebrospinal fluid proteins in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F548145

Alterations of 3-nitrotyrosine concentration in the cerebrospinal fluid during aging and in patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F548145

Cerebrospinal fluid levels of free 3-nitrotyrosine are not elevated in the majority of patients with amyotrophic lateral sclerosis or Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F548145

Alzheimer disease: correlation of cerebro-spinal fluid and brain ubiquitin levels

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F548145

Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt-Jakob disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F548145

Cerebrospinal fluid S100B is elevated in the earlier stages of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F548145

Validation of amyloid-beta peptides in CSF diagnosis of neurodegenerative dementias.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F548145

Tau and Abeta42 protein in CSF of patients with frontotemporal degeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F548145

Cerebrospinal fluid biomarkers in Parkinson's disease with dementia and dementia with Lewy bodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F548145

Amyloid beta peptides in plasma in early diagnosis of Alzheimer's disease: A multicenter study with multiplexing.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F548145

Blood-based neurochemical diagnosis of vascular dementia: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F548145

Urea-based two-dimensional electrophoresis of beta-amyloid peptides in human plasma: evidence for novel Abeta species

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F548145

Adherence-dependent shifts in the patterns of beta-amyloid peptides secreted by human mononuclear phagocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F548145

Distinct fractional Abeta release patterns in human mononuclear phagocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F548145

S-100 protein concentration in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F548145

Elevated levels of tau and ubiquitin in brain and cerebrospinal fluid in Alzheimer's disease.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945639

Ubiquitin in cerebrospinal fluid in Alzheimer's disease and vascular dementia.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2945639

Reduced CSF carboxyterminally truncated Aβ peptides in frontotemporal lobe degenerations

28 October 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F548145

Association of plasma amyloid with risk of dementia: The prospective Three-City Study

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F548145

Ubiquitin as potential cerebrospinal fluid marker of Creutzfeldtâ Jakob disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F548145

The cerebrospinal fluid levels of tau, growth-associated protein-43 and soluble amyloid precursor protein correlate in Alzheimer's disease, reflecting a common pathophysiological process

21 January 2018

1 reference

12 December 2020

Cerebrospinal fluid beta-glucocerebrosidase activity is reduced in Dementia with Lewy Bodies

1 reference

12 December 2020

Low frequency of post-lumbar puncture headache in demented patients

1 reference

12 December 2020

Levels of alpha- and beta-secretase cleaved amyloid precursor protein in the cerebrospinal fluid of Alzheimer's disease patients

1 reference

12 December 2020

Evaluation of CSF-tau and CSF-Abeta42 as diagnostic markers for Alzheimer disease in clinical practice

1 reference

12 December 2020

Searching for markers of Creutzfeldt-Jakob disease in cerebrospinal fluid by two-dimensional mapping

1 reference

12 December 2020

Lysosomal hydrolases in cerebrospinal fluid from subjects with Parkinson's disease

1 reference

12 December 2020

Proteome analysis of cerebrospinal fluid proteins in Alzheimer patients

1 reference

12 December 2020

Concentrations of beta-amyloid precursor protein processing products in cerebrospinal fluid of patients with amyotrophic lateral sclerosis and frontotemporal lobar degeneration

1 reference

12 December 2020

Identifiers

DOI

10.4061/2010/548145

1 reference

31 July 2017

1 reference

31 July 2017

1 reference